ALL 001
Alternative Names: ALL-001Latest Information Update: 21 Dec 2020
At a glance
- Originator Allero Therapeutics
- Class Immunotherapies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Coeliac disease
Most Recent Events
- 01 Dec 2020 Preclinical trials in Coeliac disease in Netherlands (PO)